Deniz Tutkunkardas (D Tutkunkardas)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Hidradenitis Suppurativa

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan Ian Silverberg, Lars Einar French, Richard B Warren, Bruce E Strober, Kim Kjøller, Morten O A Sommer, Philippe Andres, Jakob Felding, Anne Weiss, Deniz Tutkunkardas, Tine Skak-Nielsen, Emma Guttman-Yassky
Pharmacology of orismilast, a potent and selective PDE4 inhibitor. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Jonathan Ian Silverberg, Lars Einar French, Richard B Warren, Bruce E Strober, Kim Kjøller, Morten O A Sommer, Philippe Andres, Jakob Felding, Anne Weiss, Deniz Tutkunkardas, Tine Skak-Nielsen, Emma Guttman-Yassky
Pharmacology of orismilast, a potent and selective PDE4 inhibitor. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Jonathan Ian Silverberg, Lars Einar French, R B Warren, Bruce E Strober, K Kjøller, M O A Sommer, P Andres, J Felding, A Weiss, Deniz Tutkunkardas, Tine Skak-Nielsen, E Guttman
Pharmacology of orismilast, a potent and selective PDE4 inhibitor. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
R B Warren, Bruce E Strober, Jonathan Ian Silverberg, E Guttman, P Andres, J Felding, Deniz Tutkunkardas, K Kjøller, M O A Sommer, Lars Einar French
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Jonathan Ian Silverberg, Lars Einar French, Richard B Warren, Bruce E Strober, Kim Kjøller, Morten O A Sommer, Philippe Andres, Jakob Felding, Anne Weiss, Deniz Tutkunkardas, Tine Skak-Nielsen, Emma Guttman-Yassky
Pharmacology of orismilast, a potent and selective PDE4 inhibitor. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)